European Sepsis Care Survey

NCT05059808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1450

Last updated 2023-06-13

No results posted yet for this study

Summary

The objective of this survey is to investigate the current state of sepsis care around Europe. The study is aiming at hospital structure, emergency departments, wards, intensive care units and clinical diagnostic and microbiological service.

Conditions

Sponsors & Collaborators

  • European Sepsis Alliance

    collaborator UNKNOWN
  • European Society of Anaesthesiology and Intensive Care

    collaborator OTHER
  • European Society for Emergency Medicine (EUSEM) Research Network

    collaborator NETWORK
  • European Society of Clinical Microbiology and Infectious Diseases, ESGBIES Study Group

    collaborator UNKNOWN
  • European Society of Intensive Care Medicine

    collaborator OTHER
  • Sepsisdialog, Germany

    collaborator UNKNOWN
  • European Shock Society

    collaborator UNKNOWN
  • Becton, Dickinson and Company

    collaborator INDUSTRY
  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Christian S Scheer · Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany

  • Adam Linder · European Sepsis Alliance

  • Daniela Filipescu · European Sepsis Alliance, European Society of Anaesthesiology and Intensive Care

  • Evangelos Giamarellos-Bourboulis · European Sepsis Alliance, European Shock Society

  • Evgeny Idelevich · ESCMID/Study Group for Bloodstream Infections, Endocarditis and Sepsis

  • Konrad Reinhart · Global Sepsis Alliance

  • Matthias Gründling · Quality management project Sepsisdialog

  • Ricard Ferrer · European Society of Intensive Care Medicine

  • Said Laribi · European Society for Emergency Medicine (EUSEM) Research Network

  • Manu Malbrain · International Fluid Academy

  • Gabriella Bottari · European Society of Paediatric and Neonatal Intensive Care

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-04-30
Completion
2022-10-30

Countries

  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Israel
  • Italy
  • Moldova
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Russia
  • Spain
  • Sweden
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05059808 on ClinicalTrials.gov